1-(3-bromophenyl)pentan-2-ol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(3-bromophenyl)pentan-2-ol
• 英文别名: 1-(3-Bromophenyl)-2-pentanol
• 化学式: C₁₁H₁₅BrO
• 分子量: 243.143
• InChiKey: OMKISZHNIZCENG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  3-溴苄溴 在 碲化氢 作用下， 反应 0.75h， 生成 1-(3-bromophenyl)pentan-2-ol
  参考文献：
  名称：

  借助锂-碲交换反应，由相应的卤化物生成烯丙基锂和苄基锂

  摘要：

  通过从相应卤化物原位生成的烯丙基和苄基碲化物的锂-碲交换反应，可以制备各种烯丙基和苄基锂。生成的有机锂已成功被亲电子试剂（如醛，酮和三甲基氯硅烷）捕获。在THF中有效地生成在其芳族环上具有烷基，烷氧基，氟，氯或氰基取代基的苄基锂。带有溴或碘取代基的苄基碲化物在相似条件下由于竞争性的锂-卤素交换和/或使用有机锂置换卤素原子而提供了产物混合物，但在不影响卤素取代基的情况下，它们在醚中选择性地转化为苄基锂。在苯环上。经由烯丙基碲化物以类似方式由烯丙基卤化物产生包括二硫代异丁烯在内的几种烯丙基锂。在检查的任何反应中，Wurtz型偶联都可以忽略不计。

  DOI：

  10.1016/0022-328x(94)80107-x

文献信息

• 6-Membered heterocyclic compound and use thereof
  申请人：Shoda Motoshi

  公开号：US20070060590A1

  公开（公告）日：2007-03-15

  A compound represented by the general formula (I) or a salt thereof: [T represents oxygen atom and the like; V represents CH 2 and the like; R O1 to R O4 represent hydrogen atom and the like; A represents a linear alkylene group or linear alkenylene group having 2 to 8 carbon atoms and the like; D represents carboxyl group and the like; X represents ethylene group, trimethylene group and the like; E represents —CH(OH)— group and the like; and W represent —U 1 —(R W1 )(R W2 )—U 2 —U 3 group (U 1 represents a single bond, an alkylene group having 1 to 4 carbon atoms and the like; R W1 and R W2 represent hydrogen atom and the like; U 2 represents a single bond, an alkylene group having 1 to 4 carbon atoms and the like; and U 3 represent an alkyl group having 1 to 8 carbon atoms and the like), or a residue of a carbon ring or heterocyclic compound], which can be utilized as an active ingredient of medicaments effective for prophylactic and/or therapeutic treatment of skeletal diseases such as osteoporosis and fracture, glaucoma, ulcerative colitis and the like.

  由通用公式(I)表示的化合物或其盐： [T代表氧原子等；V代表CH2等；RO1至RO4代表氢原子等；A代表具有2至8个碳原子的线型亚烷基或线型亚烯基等；D代表羧基等；X代表亚乙基、亚丙基等；E代表—CH(OH)—基团等；W代表—U1—(RW1)(RW2)—U2—U3基团（U1代表单键、具有1至4个碳原子的亚烷基等；RW1和RW2代表氢原子等；U2代表单键、具有1至4个碳原子的亚烷基等；U3代表具有1至8个碳原子的烷基等），或碳环或杂环化合物的残基]，其可作为预防性和/或治疗性药物的有效成分，用于治疗骨骼疾病如骨质疏松症和骨折、青光眼、溃疡性结肠炎等。
• SIX-MEMBERED HETEROCYCLIC COMPOUND AND THE USE THEREOF
  申请人：Asahi Kasei Pharma Corporation

  公开号：EP1847533A1

  公开（公告）日：2007-10-24

  A compound represented by the general formula (I) or a salt thereof: [T represents oxygen atom and the like; V represents CH2 and the like; RO1 to RO4 represent hydrogen atom and the like; A represents a linear alkylene group or linear alkenylene group having 2 to 8 carbon atoms and the like; D represents carboxyl group and the like; X represents ethylene group, trimethylene group and the like; E represents -CH(OH)- group and the like; and W represent -U1-(RW1)(RW2)-U2-U3 group (U1 represents a single bond, an alkylene group having 1 to 4 carbon atoms and the like; RW1 and RW2 represent hydrogen atom and the like; U2 represents a single bond, an alkylene group having 1 to 4 carbon atoms and the like; and U3 represent an alkyl group having 1 to 8 carbon atoms and the like), or a residue of a carbon ring or heterocyclic compound], which can be utilized as an active ingredient of medicaments effective for prophylactic and/or therapeutic treatment of skeletal diseases such as osteoporosis and fracture, glaucoma, ulcerative colitis and the like.

  通式 (I) 所代表的化合物或其盐： [T 代表氧原子等；V 代表 CH2 等；RO1 至 RO4 代表氢原子等；A 代表具有 2 至 8 个碳原子的直链烯基或直链烯基等；D 代表羧基等；X 代表乙烯基、三亚甲基等；E 代表-CH(OH)- 基等；W 代表-U1-(RW1)(RW2)-U2-U3 基（U1 代表单键、具有 1 至 4 个碳原子的亚烷基等）；RW1 和 RW2 代表氢原子等；U2 代表单键、具有 1 至 4 个碳原子的亚烷基等；U3 代表具有 1 至 8 个碳原子的烷基等），或碳环或杂环化合物的残基]，可用作有效预防和/或治疗骨质疏松症和骨折等骨骼疾病、青光眼、溃疡性结肠炎等疾病的药物的活性成分。
• US7531533B2
  申请人：——

  公开号：US7531533B2

  公开（公告）日：2009-05-12
• Generation of allyl- and benzyllithiums from the corresponding halides by the aid of lithium-tellurium exchange reactions
  作者：Takahiro Kanda、Shinzi Kato、Takushi Sugino、Nobuaki Kambe、Noboru Sonoda

  DOI：10.1016/0022-328x(94)80107-x

  日期：1994.6

  products under similar conditions arising from the competing lithium-halogen exchange and/or the displacement of the halogen atom with organolithiums used, but they were converted selectively to benzyllithiums in ether without affecting halogen substituents on the benzene ring. Several allyllithiums including dilithioisobutene were generated from allylic halides in a similar way via allylic tellurides

  通过从相应卤化物原位生成的烯丙基和苄基碲化物的锂-碲交换反应，可以制备各种烯丙基和苄基锂。生成的有机锂已成功被亲电子试剂（如醛，酮和三甲基氯硅烷）捕获。在THF中有效地生成在其芳族环上具有烷基，烷氧基，氟，氯或氰基取代基的苄基锂。带有溴或碘取代基的苄基碲化物在相似条件下由于竞争性的锂-卤素交换和/或使用有机锂置换卤素原子而提供了产物混合物，但在不影响卤素取代基的情况下，它们在醚中选择性地转化为苄基锂。在苯环上。经由烯丙基碲化物以类似方式由烯丙基卤化物产生包括二硫代异丁烯在内的几种烯丙基锂。在检查的任何反应中，Wurtz型偶联都可以忽略不计。